High specificity of quantitative methylation-specific pcr analysis for mgmt promoter hypermethylation detection in gliomas

Journal of Biomedicine and Biotechnology

Volumn 2009, Issue , 2009, Pages

  Parrella, Paola ^a   La Torre, Antonella ^a   Copetti, Massimiliano ^a   Valori, Vanna M ^a   Barbano, Raffaela ^a   Notarangelo, Angelo ^a   Bisceglia, Michele ^a   Gallo, Antonietta Pia ^a   Balsamo, Teresa ^a   Poeta, Maria Luana ^b   Carella, Massimo ^a   Catapano, Domenico ^a   Parisi, Salvatore ^a   Dallapiccola, Bruno ^a   Maiello, Evaristo ^a   D'Angelo, Vincenzo ^a   Fazio, Vito Michele ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; TEMOZOLOMIDE; DNA METHYLTRANSFERASE; MGMT PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; ASTROCYTOMA; BRAIN TISSUE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DETERMINATION; DNA METHYLATION; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN TISSUE; MALE; OLIGODENDROGLIOMA; PATIENT SELECTION; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; AREA UNDER THE CURVE; BRAIN; BRAIN LEVEL; GENETICS; GLIOMA; METABOLISM; METHODOLOGY; MIDDLE AGED; NONPARAMETRIC TEST; POLYMERASE CHAIN REACTION; ROC CURVE;

AREA UNDER CURVE; BRAIN; BRAIN CHEMISTRY; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GLIOMA; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC; ROC CURVE; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR SUPPRESSOR PROTEINS;

EID: 67650930124     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2009/531692     Document Type: Article

References (39)

1. Louis D. N., Ohgaki H., Wiestler O. D., The 2007 WHO classification of tumours of the central nervous system Acta Neuropathologica 2007 114 2 97 109
2. Stupp R., Mason W. P., van den Bent M. J., Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma The New England Journal of Medicine 2005 352 10 987 996
3. van den Bent M. J., Carpentier A. F., Brandes A. A., Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Cancer phase III trial Journal of Clinical Oncology 2006 24 18 2715 2722
4. Cairncross G., Berkey B., Shaw E., Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group trial 9402 Journal of Clinical Oncology 2006 24 18 2707 2714
5. Esteller M., Garcia-Foncillas J., Andion E., Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents The New England Journal of Medicine 2000 343 19 1350 1354
6. Hegi M. E., Diserens A.-C., Godard S., Clinical trial substantiates the predictive value of O 6-methylguanine-DNA methyltransferase promoter methylation in glioblastoma patients treated with temozolomide Clinical Cancer Research 2004 10 6 1871 1874
7. Hegi M. E., Diserens A.-C., Gorlia T., MGMT gene silencing and benefit from temozolomide in glioblastoma The New England Journal of Medicine 2005 352 10 997 1003
8. Gerson S. L., MGMT: its role in cancer aetiology and cancer therapeutics Nature Reviews Cancer 2004 4 4 296 307
9. Singer-Sam J., LeBon J. M., Tanguay R. L., Riggs A. D., A quantitative HpaII-PCR assay to measure methylation of DNA from a small number of cells Nucleic Acids Research 1990 18 3 687
10. Frommer M., McDonald L. E., Millar D. S., A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands Proceedings of the National Academy of Sciences of the United States of America 1992 89 5 1827 1831
11. Huang T. H.-M., Perry M. R., Laux D. E., Methylation profiling of CpG islands in human breast cancer cells Human Molecular Genetics 1999 8 3 459 470
12. Herman J. G., Graff J. R., Myohanen S., Nelkin B. D., Baylin S. B., Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands Proceedings of the National Academy of Sciences of the United States of America 1996 93 18 9821 9826
13. An Q., Liu Y., Gao Y., Detection of p16 hypermethylation in circulating plasma DNA of non-small cell lung cancer patients Cancer Letters 2002 188 1-2 109 114
14. Ogino S., Odze R. D., Kawasaki T., Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma American Journal of Surgical Pathology 2006 30 9 1175 1183
15. Colella S., Shen L., Baggerly K. A., Issa J.-P. J., Krahe R., Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites BioTechniques 2003 35 1 146 150
16. Mikeska T., Bock C., EI-Maarri O., Optimization of quantitative MGMT promoter methylation analysis using Pyrosequencing and combined bisulfite restriction analysis Journal of Molecular Diagnostics 2007 9 3 368 381
17. Cankovic M., Mikkelsen T., Rosenblum M. L., Zarbo R. J., A simplified laboratory validated assay for MGMT promoter hypermethylation analysis of glioma specimens from formalin-fixed paraffin-embedded tissue Laboratory Investigation 2007 87 4 392 397
18. Derks S., Lentjes M. H., Hellebrekers D. M., de Brune A. P., Herman J. G., van Engeland M., Methylation-specific PCR unraveled Cellular Oncology 2004 26 5-6 291 299
19. Esteller M., Hamilton S. R., Burger P. C., Baylin S. B., Herman J. G., Inactivation of the DNA repair gene O 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Research 1999 59 4 793 797
20. Harden S. V., Sanderson H., Goodman S. N., Partin A.A.W., Walsh P. C., Epstein J. I., Sidransky D., Quantitative GSTP1 methylation and the detection of prostate adenocarcinoma in sextant biopsies Journal of the National Cancer Institute 2003 95 21 1634 1637
21. Reesink-Peters N., Wisman G.B. A., Jeronimo C., Detecting cervical cancer by quantitative promoter hypermethylation assay on cervical scrapings: a feasibility study Molecular Cancer Research 2004 2 5 289 295
22. Hoque M. O., Begum S., Topaloglu O., Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection Journal of the National Cancer Institute 2006 98 14 996 1004
23. Schmiemann V., Bcking A., Kazimirek M., Methylation assay for the diagnosis of lung cancer on bronchial aspirates: a cohort study Clinical Cancer Research 2005 11 21 7728 7734
24. Kahn S. L., Ronnett B. M., Gravitt P. E., Gustafson K. S., Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests Cancer 2008 114 1 57 64
25. Fackler M. J., McVeigh M., Mehrotra J., Quantitative multiplex methylation-specific PCR assay for the detection of promoter hypermethylation in multiple genes in breast cancer Cancer Research 2004 64 13 4442 4452
26. Lo Y. M. D., Wong I. H. N., Zhang J., Tein M. S. C., Ng M. H. L., Hjelm N. M., Quantitative analysis of aberrant p16 methylation using real-time quantitative methylation-specific polymerase chain reaction Cancer Research 1999 59 16 3899 3903
27. Belinsky S. A., Liechty K. C., Gentry F. D., Promoter hypermethylation of multiple genes in sputum precedes lung cancer incidence in a high-risk cohort Cancer Research 2006 66 6 3338 3344
28. Eads C. A., Danenberg K. D., Kawakami K., MethyLight: a high-throughput assay to measure DNA methylation Nucleic Acids Research 2000 28 8, article E32 1 8
29. Jeronimo C., Usadel H., Henrique R., Quantitation of GSTP1 methylation in non-neoplastic prostatic tissue and organ-confined prostate adenocarcinoma Journal of the National Cancer Institute 2001 93 22 1747 1752
30. Vlassenbroeck I., Califice S., Diserens A.-C., Validation of real-time methylation-specific PCR to determine O 6 -methylguanine-DNA methyltransferase gene promoter methylation in glioma Journal of Molecular Diagnostics 2008 10 4 332 337
31. Hoque M. O., Kim M. S., Ostrow K. L., Genome-wide promoter analysis uncovers portions of the cancer methylome Cancer Research 2008 68 8 2661 2670
32. Hu M., Yao J., Cai L., Distinct epigenetic changes in the stromal cells of breast cancers Nature Genetics 2005 37 8 899 905
33. Parrella P., Xiao Y., Fliss M., Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates Cancer Research 2001 61 20 7623 7626
34. Parrella P., Sidransky D., Merbs S. L., Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway Cancer Research 1999 59 13 3032 3037
35. van der Riet P., Karp D., Farmer E., Progression of basal cell carcinoma through loss of chromosome 9q and inactivation of a single p53 allele Cancer Research 1994 54 1 25 27
36. Parrella P., Poeta M. L., Gallo A. P., Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors Clinical Cancer Research 2004 10 16 5349 5354
37. Landis J. R., Koch G. G., The measurement of observer agreement for categorical data Biometrics 1977 33 1 159 174
38. Fraga M. F., Esteller M., DNA methylation: a profile of methods and applications BioTechniques 2002 33 3 632 649
39. Ehrich M., Nelson M. R., Stanssens P., Quantitative high-throughput analysis of DNA methylation patterns by base-specific cleavage and mass spectrometry Proceedings of the National Academy of Sciences of the United States of America 2005 102 44 15785 15790